Cover Image

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives

Prashanth Rawla,1 Tagore Sunkara,2 Jeffrey Pradeep Raj3 1Department of Internal Medicine, Memorial Hospital of Martinsville and Henry County, Martinsville, VA, 2Division of Gastroenterology and Hepatology, The Brooklyn Hospital Center, Clinical Affiliate of The Mount Sinai Hospital, New York, NY, US...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rawla P (Author), Sunkara T (Author), Raj JP (Author)
Format:	Book
Published:	Dove Medical Press, 2018-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fecal microbiota transplant – a new frontier in inflammatory bowel disease
by: Sunkara T, et al.
Published: (2018)

Biosimilars in India; current status and future perspectives
by: Bikash R Meher, et al.
Published: (2019)

Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives
by: Wellens J, et al.
Published: (2023)

Current trends and future perspectives of natural polymer loaded nanoparticle based drug delivery system for the management of inflammatory bowel disease
by: Ankita Basak, et al.
Published: (2023)

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
by: Zhen Zeng, et al.
Published: (2024)

Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future
by: Manish Manrai, et al.
Published: (2024)

Biosimilars: Current regulatory perspective and challenges
by: Diwakar Jha, et al.
Published: (2013)

Public deliberation to assess patient views on biosimilar medication switching for the treatment of inflammatory bowel disease
by: Kerry A. Ryan, et al.
Published: (2024)

Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence
by: Valeria Dipasquale, et al.
Published: (2022)

Biological Therapy for Inflammatory Bowel Disease
Published: (2020)

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab
by: Krupka N, et al.
Published: (2014)

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study
by: Fang Wang, et al.
Published: (2023)

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
by: Zvonimir Petric, et al.
Published: (2022)

Ultrasound in Pediatric Inflammatory Bowel Disease-A Review of the State of the Art and Future Perspectives
by: André Hoerning, et al.
Published: (2024)

Review of the safety with biologics in inflammatory bowel disease
by: Andrea Pascual, et al.
Published: (2022)

Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?
by: Daniel C. Baumgart, et al.
Published: (2019)

The Role of Cytokines in Inflammatory Bowel Disease
by: G. Radford-Smith, et al.
Published: (1994)

Dental hygiene and noncommunicable diseases - Current trends and future perspective
by: L V Simhachalam Kutikuppala, et al.
Published: (2022)

Pathology of Inflammatory Bowel Disease
by: Shiva Raj K.C
Published: (2015)

Pediatric Inflammatory Bowel Diseases: Looking to the Future
Published: (2020)

Editorial: Biological drugs and biosimilars in autoimmune diseases
by: Anna Wajda, et al.
Published: (2023)

Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
by: Aoife P. Smith, et al.
Published: (2022)

Biosimilars - drugs of the future
by: E. A. Eltcova, et al.
Published: (2014)

Biologics and the timing of operative management of pediatric inflammatory bowel disease
by: Tamara Sharf, et al.
Published: (2023)

Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectives
by: Azhar U. Khan, et al.
Published: (2021)

Current and emerging drugs for the treatment of inflammatory bowel disease
by: Triantafillidis JK, et al.
Published: (2011)

Current issues of pediatric inflammatory bowel disease in Korea
by: Seak Hee Oh, et al.
Published: (2014)

The microbiota in inflammatory bowel disease: current and therapeutic insights
by: Lane ER, et al.
Published: (2017)

Drug development for the irritable bowel syndrome: current challenges and future perspectives
by: Fabrizio eDe Ponti
Published: (2013)

Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
by: Eytan Wine, et al.
Published: (2020)

Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms
by: Joanna Balding, et al.
Published: (2004)

Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives
by: Shi W, et al.
Published: (2022)

Role of Vitamin B12 and folate in metabolic syndrome - Current trends and future perspectives
by: Kowshik Chandramahanti, et al.
Published: (2023)

Risk of Infections of Biological Therapies with Accent on Inflammatory Bowel Disease
by: Radu M Nanau, et al.
Published: (2014)

Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
by: Bruno Rafael Ramos de Mattos, et al.
Published: (2015)

Inflammatory bowel diseases in pregnant women - current state of knowledge
by: Karolina Góra, et al.
Published: (2023)

Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
by: Sanghamitra M. Misra
Published: (2014)

Current status of image-enhanced endoscopy in inflammatory bowel disease
by: Young Joo Yang
Published: (2023)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
by: Gilles Duvoisin, et al.
Published: (2017)

Perspective, perceptions, and promulgation of biosimilars: A questionnaire-based study to assess and understand the current challenges of biosimilars to the potential and intended users
by: Krishan Kumar Bhardwaj, et al.
Published: (2020)